CoreHip - Post Market Clinical Follow-Up Study

NCT ID: NCT03685110

Last Updated: 2025-03-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

248 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-10-16

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is designed as a prospective, non-interventional multicentre cohort study. The product under Investigation will be used in Routine clinical practice and according to the authorized Instructions for Use (IfU). Aim of this observational study is to collect clinical and radiological results of the CoreHip® endoprosthesis system in a Standard Patient Population and when used in Routine clinical practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The CoreHip® System has a range of different stem designs to address most of the indications and anatomical conditions met in Primary THA patients within one implant and Instrument System.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Degenerative Osteoarthritis Rheumatic Arthritis Fractures, Hip Necrosis, Femur Head

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CoreHip

Clinical and Radiological Data of 300 patients of a Standard Patient Population, who are treated with CoreHip Total Hip Arthroplasty for Indications according to the Instructions for Use (IfU) with a five year follow Up

CoreHip Total Hip Arthroplasty

Intervention Type DEVICE

Replacement of the Hip Joint

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CoreHip Total Hip Arthroplasty

Replacement of the Hip Joint

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient age ≥ 18 years
* Indication for THA with a CoreHip® stem
* Written informed consent

Exclusion Criteria

* Pregnancy
* Patient age \< 18 years
* Patient not able to regularly participate at the follow-up examinations
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aesculap AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Henning Windhagen, Prof. Dr. med.

Role: PRINCIPAL_INVESTIGATOR

Orthopädische Kliniken im Annastift, Medizinische Hochschule Hannover

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ortrhopädische Klinik Markgröningen

Markgröningen, Baden-Wurttemberg, Germany

Site Status

Orthopädische Chirurgie München

München, Bavaria, Germany

Site Status

MHH

Hanover, Lower Saxony, Germany

Site Status

St. Josefs Krankenhaus Endoprothetik Zentrum

Salzkotten, , Germany

Site Status

Spital Brig

Brig, , Switzerland

Site Status

Luzerner Kantonsspital Sursee

Sursee, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AAG-O-H-1509

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hip Prospective Study
NCT05956236 RECRUITING
Avenir® Cemented Hip Stem - PMCF
NCT03396224 ACTIVE_NOT_RECRUITING
CoCrMo LOCK Bipolar Femoral Heads FU
NCT06885359 NOT_YET_RECRUITING